Pharmaguy's Insights Into Drug Industry News
186.0K views | +14 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

Sales Reps’ 10 New Year’s Resolutions for the Pharma Industry

Sales Reps’ 10 New Year’s Resolutions for the Pharma Industry | Pharmaguy's Insights Into Drug Industry News | Scoop.it

With 2017 right around the corner, how did 2016 stack up for the pharmaceutical industry? What does it mean for the future of the industry? What about those who are looking for a career in pharma and are looking for pharmaceutical sales jobs?

 

#1: Being honest about high salaries for CEO and top executives. To average folks, the numbers are simply astounding. Drug prices are constantly rising, and so are the salaries of top executives. Why is the price of medicine so high? Why does the average CEO need to make nearly $15 million per year (higher than all other major business sectors)? This has led to a high level of distrust and a belief that these top-level execs are downright greedy. There must be a happy medium.

 

Further Reading:

  • “More Top Executives Flee Sinking Crooked Valeant Ship with $ Millions in Bonuses In Tow”; http://sco.lt/6Gm6Ph
  • “Oh Snap! Regeneron CEO Says What to Pfizer CEO Ian Read???”; http://sco.lt/8ZED0T
  • “Pharma CEO Rips Insurance CEOs a New One! Exposes Salaries, Blames Them for High Drug Prices”; http://sco.lt/6kN065

 

#2: Fixing the price-fix problem.

 

Further Reading:

 

#3: Meeting growing customer expectations.

 

#4: Resolving the EpiPen controversy. Outrage continues to grow over the soaring cost of Mylan’s EpiPen.Even Martin Shkreli, who became the poster boy for jacking up drug prices, called Mylan executives “vultures” for the price hike.

 

Further Reading:

  • “Mylan, EpiPen Price Gouger, Ranks No. 2 in U.S. #Pharma Exec Pay!”; http://sco.lt/6lVvf7
  • “Yes, Mylan DID Misclassify EpiPen as a Generic, Says Medicaid”; http://sco.lt/5aJWEb
  • “Mylan CEO's Mom Used Position with Education Group to Boost EpiPen Sales Nationwide”; http://sco.lt/8tL3kP

 

More…

 

 

Pharma Guy's insight:

Also read: “Pharmaguy's Top Five 2017 New Year's Resolutions for the Pharma Industry”; http://sco.lt/7wwvLd 

more...
No comment yet.
Rescooped by Pharma Guy from Pharma Marketing News, Views & Events
Scoop.it!

Pharmaguy's Top Five 2017 New Year's Resolutions for the Pharma Industry

Pharmaguy's Top Five 2017 New Year's Resolutions for the Pharma Industry | Pharmaguy's Insights Into Drug Industry News | Scoop.it

As is my tradition – as well as the tradition for many other editors/pundits – it’s time for me to tell pharma what I’d like to see included in its list of 2017 New Year's Resolutions.

Last year I noted that 2015 wasn’t an especially good year considering that “the media and politicians have found a face for evil pharma and rising drug prices: Martin Shkreli!” (here).

It’s déjà vu all over again! Only this time many more evil pharma faces have come forward including the CEO of Mylan, aka “Pharma Sis” (read “Mylan ‘Gamed the System’ and Refuses to Testify at Senate Hearing About EpiPen Costs to Medicaid”), and top executives at “Crooked Valeant” (read “More Top Executives Flee Sinking Crooked Valeant Ship with $ Millions in Bonuses In Tow”).

 

Before getting to this year's resolutions, let's see if the industry followed any of the resolutions I suggested for 2016. More...

more...
No comment yet.